Howmet Aerospace reported a series of insider transactions and corporate financing steps this month. According to a Form 4 filing with the Securities and Exchange Commission, Executive Vice President and Chief Administrative Officer Neil Edward Marchuk sold a total of 45,150 shares of Howmet common stock on February 18, 2026. The block sale generated approximately $11.36 million, with execution prices ranging from $250.07 to $253.00 per share.
The filing also shows Marchuk disposed of 28,651 shares on February 16, 2026, to satisfy tax obligations stemming from the vesting of a stock award. That February 16 transaction was reported at a price of $250.21 per share and valued at $7,168,766.
In related paperwork, Marchuk is recorded as having acquired 3,881 shares on February 17, 2026, representing restricted share unit awards. That acquisition is listed with a reported value of $0 in the filing, consistent with the administrative conversion of vested awards into shares.
After these moves, Marchuk directly holds 107,008 shares of Howmet Aerospace common stock. The filing further notes indirect ownership of 10 shares held through a revocable trust.
Beyond insider activity, Howmet announced a planned public offering of notes totaling $1.2 billion to finance its proposed acquisition of Consolidated Aerospace Manufacturing, LLC. The financing package is broken into three tranches: $400 million of 3.750% notes due 2028, $300 million of 3.900% notes due 2029, and $500 million of 4.750% notes due 2036.
The acquisition itself is structured as an all-cash transaction valued at approximately $1.8 billion, and the company said the deal is expected to close in the first half of 2026, subject to regulatory approval.
Howmet provided projections for the acquired business, estimating revenue in the range of $485 million to $495 million for fiscal year 2026. The company also indicated an adjusted EBITDA margin in excess of 20% prior to accounting for synergies.
In addition to the financing and acquisition disclosures, investment bank UBS adjusted its valuation view on Howmet, raising its price target to $260 from $228 while maintaining a Neutral rating. UBS cited strong execution and record EBITDA margins in its rationale for the target increase.
Howmet also declared a quarterly dividend of $0.12 per share, payable on February 25, 2026, to shareholders of record as of February 6, 2026.
Taken together, the SEC filing and corporate announcements outline recent senior officer stock sales related to award vesting, the company’s plans to access the public debt markets to fund a near-term acquisition, external analyst reassessment of valuation, and a scheduled cash dividend.